Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

BACKGROUND: Aldosterone is elevated in chronic kidney disease (CKD) and may be involved in hypertension. Surprisingly, the determinants of the plasma aldosterone concentration (PAC) and its role in hypertension are not well studied in CKD. Therefore, we studied the determinants of aldosterone and it...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Nephrol
Autors principals: Gant, Christina M., Laverman, Gozewijn D., Vogt, Liffert, Slagman, Maartje C. J., Heerspink, Hiddo J. L., Waanders, Femke, Hemmelder, Marc H., Navis, Gerjan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738866/
https://ncbi.nlm.nih.gov/pubmed/29262813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0789-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars